Citation

Cui JJ, McTigue M, Nambu M, Tran-Dubé M, Pairish M, Shen H, Jia L, Cheng H, Hoffman J, Le P, Jalaie M, Goetz GH, Ryan K, Grodsky N, Deng YL, Parker M, Timofeevski S, Murray BW, Yamazaki S, Aguirre S, Li Q, Zou H, Christensen J.: Discovery of a novel class of exquisitely selective mesenchymal-epithelial transition factor (c-MET) protein kinase inhibitors and identification of the clinical candidate 2-(4-(1-(quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol (PF-04217903) for the treatment of cancer. J Med Chem, Volume 55 (18), 2012

Authors

Aguirre S, Cheng H, Christensen J., Cui JJ, Deng YL, Goetz GH, Grodsky N, Hoffman J, Jalaie M, Jia L, Le P, Li Q, McTigue M, Murray BW, Nambu M, Pairish M, Parker M, Ryan K, Shen H, Timofeevski S, Tran-Dubé M, Yamazaki S, Zou H

Journal

J Med Chem

Year

2012

DOI

10.1021/jm300967g

PubMed

22924734

Machine-readable

REST APIRDF